GetTopicDetailResponse(id=923211184230, topicName=顱內(nèi)療效, introduction=顱內(nèi)療效, content=NSCLC 拉澤替尼 顱內(nèi)療效, image=null, comments=0, allHits=932, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Mar 03 07:25:48 CST 2024, time=2024-03-03, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=487743, tagList=[TagDto(tagId=487743, tagName=顱內(nèi)療效)], ipAttribution=威斯康星, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2190683, encodeId=28292190683fe, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=c64a10641526' target=_blank style='color:#2F92EE;'>#拉澤替尼#</a> <a href='/topic/show?id=923211184230' target=_blank style='color:#2F92EE;'>#顱內(nèi)療效#</a>, objectTitle=J Thorac Oncol：LASER301研究亞組分析：拉澤替尼顯著改善EGFR突變NSCLC腦轉移患者顱內(nèi)PFS, objectType=article, longId=815683, objectId=a23e81568371, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240302/1709387233134_6145188.jpg, objectUrl=/article/show_article.do?id=a23e81568371, replyNumber=0, likeNumber=132, createdTime=2024-03-03, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=a23e81568371, moduleTitle=J Thorac Oncol：LASER301研究亞組分析：拉澤替尼顯著改善EGFR突變NSCLC腦轉移患者顱內(nèi)PFS, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a23e81568371)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-03-03發(fā)表于威斯康星
